Colorectal cancer (CRC) is the third most common cancer occurring in men and...
FDA allows Senseonics to market Eversense CGM System
The US Food and Drug Administration (FDA) has approved Senseonics Holdings’ Premarket Approval (PMA) application to market its Eversense Continuous Glucose Monitoring (CGM) System.
Deals and M&As this week: Syncona, Medrobotics, Micrima
Syncona Ltd has completed the acquisition of a surgical platform for sub-retinal delivery from Janssen Biotech Inc.
JenaValve Technology begins CE Mark study of Pericardial TAVR System
Transcatheter aortic valve replacement (TAVR) systems manufacturer JenaValve Technology has started patient enrolment and implantations for the CE Mark study of its new JenaValve Pericardial TAVR System.
Bay Labs’ EchoMD AutoEF Software secures FDA clearance
Medical technology company Bay Labs has announced that its EchoMD AutoEF software product has secured US Food and Drug Administration (FDA) clearance.
The world’s biggest healthcare companies in 2018
The healthcare companies that achieved high revenue in 2017 focused on providing innovative healthcare services and products. Mergers and acquisitions of smaller healthcare companies were also one of the key strategies adopted. Medicaldevices-technology.com lists the world’s biggest healthcare companies based on 2017 revenues.
Researchers developing method to preserve fertility in boys with cancer
Researchers at Israel’s Ben-Gurion University of the Negev (BGU), along with Soroka University Medical Center, are developing a new cell culture system to transform testicular STEM cells into sperm-like cells.
FDA clears Arcuro’s SuperBall meniscus repair system
The US Food and Drug Administration (FDA) has awarded regulatory clearance for the Arcuro Medical’s (Arcuro) SuperBall meniscus repair system.
Neural Analytics secures CE Mark for robotic ultrasound system
US-based medical robotics company Neural Analytics has received a CE Mark for its new robotic ultrasound solution called NeuralBot System.
The changing landscape of colorectal cancer screening
Colorectal cancer (CRC) is the third most common cancer occurring in men and the second most common cancer in women. In addition to inflicting devastating personal costs on patients, CRC places a sizable economic burden on national healthcare systems.
Read our magazine
Medical Technology is the essential reading material for decision-makers in the medical device industry, bringing you the latest news and analysis in an exciting, interactive format.